Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy

Purpose: To analyze the ocular surface changes in eyes after the withdrawal of anti-glaucomatous drugs when non-penetrating deep sclerectomy (NPDS) is performed. Methods: Thirty-one patients (33 eyes) diagnosed with glaucoma that underwent NPDS were included in this prospective study. The control gr...

Full description

Bibliographic Details
Main Authors: Carlota Fuente-García, Francisco José Muñoz-Negrete, Elisabet de Dompablo, Javier Moreno-Montañés, Gema Rebolleda
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Ophthalmology
Subjects:
Online Access:http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1626;epage=1633;aulast=Fuente-García
_version_ 1811244791015407616
author Carlota Fuente-García
Francisco José Muñoz-Negrete
Elisabet de Dompablo
Javier Moreno-Montañés
Gema Rebolleda
author_facet Carlota Fuente-García
Francisco José Muñoz-Negrete
Elisabet de Dompablo
Javier Moreno-Montañés
Gema Rebolleda
author_sort Carlota Fuente-García
collection DOAJ
description Purpose: To analyze the ocular surface changes in eyes after the withdrawal of anti-glaucomatous drugs when non-penetrating deep sclerectomy (NPDS) is performed. Methods: Thirty-one patients (33 eyes) diagnosed with glaucoma that underwent NPDS were included in this prospective study. The control group included 33 eyes. Four variables were studied using Keratograph 5M (K5M): ocular hyperemia (OH), non-invasive tear film break-up time (NI-BUT), lower tear meniscus height (LTMH), and meibography. LTMH was also measured using the anterior segment module of a Spectralis Fourier-domain optical coherence tomography (FD-OCT) instrument. Moreover, an evaluation of corneal and conjunctival staining was performed. In the glaucoma group, five visits were carried out: pre-surgery, 1 week after surgery, and 1 month, 3 months, and 6 months after surgery. In control groups, examinations were performed in only one visit. In addition, patients were asked to answer two questionnaires: Ocular Surface Disease Index (OSDI) and National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) before and 6 months after surgery. Results: Before NPDS, eyes showed worse objective data than healthy control subjects (P ≤ 0.049). In this group, a significant improvement was observed in questionnaire responses (P < 0.001), LTMH-FD-OCT (P = 0.037), LTMH-K5M (P = 0.025), K5M-OH (P = 0.003), NI-BUT (P = 0.022), and conjunctival and corneal staining (P < 0.001). No significant differences were observed between groups in FD-OCT and K5M LTMH, NI-BUT, corneal-conjunctival staining, nor in the most OH sector values at 6 months (P ≥ 0.62). Conclusion: A significant improvement in the ocular surface was observed 6 months after NPDS, suggesting that the withdrawal of the topical anti-glaucomatous treatment had a beneficial effect on the subjects.
first_indexed 2024-04-12T14:31:06Z
format Article
id doaj.art-f9c20c4d0580427aa091b750dbe2f3a5
institution Directory Open Access Journal
issn 0301-4738
1998-3689
language English
last_indexed 2024-04-12T14:31:06Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Ophthalmology
spelling doaj.art-f9c20c4d0580427aa091b750dbe2f3a52022-12-22T03:29:17ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892022-01-017051626163310.4103/ijo.IJO_2654_21Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomyCarlota Fuente-GarcíaFrancisco José Muñoz-NegreteElisabet de DompabloJavier Moreno-MontañésGema RebolledaPurpose: To analyze the ocular surface changes in eyes after the withdrawal of anti-glaucomatous drugs when non-penetrating deep sclerectomy (NPDS) is performed. Methods: Thirty-one patients (33 eyes) diagnosed with glaucoma that underwent NPDS were included in this prospective study. The control group included 33 eyes. Four variables were studied using Keratograph 5M (K5M): ocular hyperemia (OH), non-invasive tear film break-up time (NI-BUT), lower tear meniscus height (LTMH), and meibography. LTMH was also measured using the anterior segment module of a Spectralis Fourier-domain optical coherence tomography (FD-OCT) instrument. Moreover, an evaluation of corneal and conjunctival staining was performed. In the glaucoma group, five visits were carried out: pre-surgery, 1 week after surgery, and 1 month, 3 months, and 6 months after surgery. In control groups, examinations were performed in only one visit. In addition, patients were asked to answer two questionnaires: Ocular Surface Disease Index (OSDI) and National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) before and 6 months after surgery. Results: Before NPDS, eyes showed worse objective data than healthy control subjects (P ≤ 0.049). In this group, a significant improvement was observed in questionnaire responses (P < 0.001), LTMH-FD-OCT (P = 0.037), LTMH-K5M (P = 0.025), K5M-OH (P = 0.003), NI-BUT (P = 0.022), and conjunctival and corneal staining (P < 0.001). No significant differences were observed between groups in FD-OCT and K5M LTMH, NI-BUT, corneal-conjunctival staining, nor in the most OH sector values at 6 months (P ≥ 0.62). Conclusion: A significant improvement in the ocular surface was observed 6 months after NPDS, suggesting that the withdrawal of the topical anti-glaucomatous treatment had a beneficial effect on the subjects.http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1626;epage=1633;aulast=Fuente-Garcíaglaucomakeratographnon-penetrating deep sclerectomyocular hyperemiaocular surface disease
spellingShingle Carlota Fuente-García
Francisco José Muñoz-Negrete
Elisabet de Dompablo
Javier Moreno-Montañés
Gema Rebolleda
Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy
Indian Journal of Ophthalmology
glaucoma
keratograph
non-penetrating deep sclerectomy
ocular hyperemia
ocular surface disease
title Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy
title_full Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy
title_fullStr Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy
title_full_unstemmed Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy
title_short Changes in ocular surface after withdrawal of anti-glaucoma medications following non-penetrating deep sclerectomy
title_sort changes in ocular surface after withdrawal of anti glaucoma medications following non penetrating deep sclerectomy
topic glaucoma
keratograph
non-penetrating deep sclerectomy
ocular hyperemia
ocular surface disease
url http://www.ijo.in/article.asp?issn=0301-4738;year=2022;volume=70;issue=5;spage=1626;epage=1633;aulast=Fuente-García
work_keys_str_mv AT carlotafuentegarcia changesinocularsurfaceafterwithdrawalofantiglaucomamedicationsfollowingnonpenetratingdeepsclerectomy
AT franciscojosemunoznegrete changesinocularsurfaceafterwithdrawalofantiglaucomamedicationsfollowingnonpenetratingdeepsclerectomy
AT elisabetdedompablo changesinocularsurfaceafterwithdrawalofantiglaucomamedicationsfollowingnonpenetratingdeepsclerectomy
AT javiermorenomontanes changesinocularsurfaceafterwithdrawalofantiglaucomamedicationsfollowingnonpenetratingdeepsclerectomy
AT gemarebolleda changesinocularsurfaceafterwithdrawalofantiglaucomamedicationsfollowingnonpenetratingdeepsclerectomy